Phase 1B Drug-Drug Interaction Safety Trial of CS-1103 and a Relevant Challenge with IV Methamphetamine
RELEVANCE: There are no FDA approved medications for the treatment of Methamphetamine Use Disorder (MUD). Current treatment options rely heavily on counseling and behavioral interventions. Scientific evidence supports a combination strategy of pharmacotherapy approaches with behavioral therapies to improve patient outcomes and redefine treatment approach for stimulant use disorder. DESCRIPTION: Clear Scientific has developed CS-1103, the first rationally derived small molecule that has capacity for removing methamphetamine from the body. Funded by a grant from…